[PMS] LINZESS Tablet 0.25mg Long-term Specified Drug Use-results Survey in Patients With Irritable Bowel Syndrome With Constipation or Chronic Constipation (Excluding Constipation Due to Organic Diseases)
Phase of Trial: Phase IV
Latest Information Update: 16 Nov 2018
At a glance
- Drugs Linaclotide (Primary)
- Indications Constipation; Irritable bowel syndrome
- Focus Adverse reactions
- Sponsors Astellas Pharma
- 25 Oct 2018 Treatment arm has been added for patients with chronic constipation. Planned patients number has increased.
- 25 Oct 2018 Planned number of patients changed from 1000 to 2000.
- 23 Mar 2018 New trial record